Journal of Autoimmunity · 2022 · 10 citations · 16 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryNeurodegenerationLipid-based NanoparticlesMultiple SclerosisNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsOral NanocarriersComparative Effectiveness TrialsFumarate TherapyLipid Nanoparticle DeliveryLipid Nanoparticle Delivery SystemsLipid NanoparticlesLipid-based Nanoparticle FormulationMultiple Sclerosis NeuroprotectionMultiple Sclerosis Therapy
16
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold, Ludwig Kappos, Douglas L. Arnold et al. · New England Journal of Medicine · 2012 · 1.7K citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells
Felix Treumer, Kejian Zhu, Regine Gläser et al. · Journal of Investigative Dermatology · 2003 · 249 citations · Full text